Convalescent Plasma Trial in COVID -19 Patients
Use of Convalescent Plasma Therapy for COVID-19 Patients With Hypoxia: a Prospective Randomized Trial
Sponsor: Bahrain Defence Force Hospital
This NA trial investigates COVID-19 and SARS-CoV 2 and is currently completed. Bahrain Defence Force Hospital leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Nov 2021 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 3 earlier versions
-
Jul 2020 — Aug 2020 [monthly]
Recruiting NA
-
Jun 2020 — Jul 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2020 — Jun 2020 [monthly]
Not Yet Recruiting NA
First recorded
Apr 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bahrain Defence Force Hospital
- Mohammed Bin Khalifa Bin Sulman Al Khalifa Cardiac Centre, Awali
- Royal College of Surgeons in Ireland - Medical University of Bahrain
- Salmaniya Medical Complex
For direct contact, visit the study record on ClinicalTrials.gov .